PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34101869-8	2021	Murine HCC models developed by HT methods showed that a high YAP/TAZ activity in HCC cells impaired verteporfin penetration into the cancer.	Verteporfin	100-111	yes-associated protein 1	Mus musculus	61-64	
34101869-8	2021	Murine HCC models developed by HT methods showed that a high YAP/TAZ activity in HCC cells impaired verteporfin penetration into the cancer.	Verteporfin	100-111	tafazzin, phospholipid-lysophospholipid transacylase	Mus musculus	65-68	
34101869-10	2021	Consistent with the findings in the in vivo models of HCC, MCHOs with activated YAP/TAZ signaling showed stromal activation and impaired penetration of verteporfin into the tumor organoids.	mchos	59-64	yes-associated protein 1	Mus musculus	80-83	
34101869-10	2021	Consistent with the findings in the in vivo models of HCC, MCHOs with activated YAP/TAZ signaling showed stromal activation and impaired penetration of verteporfin into the tumor organoids.	mchos	59-64	tafazzin, phospholipid-lysophospholipid transacylase	Mus musculus	84-87	
34101869-10	2021	Consistent with the findings in the in vivo models of HCC, MCHOs with activated YAP/TAZ signaling showed stromal activation and impaired penetration of verteporfin into the tumor organoids.	Verteporfin	152-163	yes-associated protein 1	Mus musculus	80-83	
34101869-10	2021	Consistent with the findings in the in vivo models of HCC, MCHOs with activated YAP/TAZ signaling showed stromal activation and impaired penetration of verteporfin into the tumor organoids.	Verteporfin	152-163	tafazzin, phospholipid-lysophospholipid transacylase	Mus musculus	84-87